Arthur E. Frankel, who helped to interpret the clinical relevance of the findings, was inadvertently omitted from the authors list during the final stages of production. This has now been corrected in both the PDF and HTML versions of the Article.
Additional information
The online version of the original article can be found at 10.1038/ncomms12336
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Eskiocak, U., Ramesh, V., Gill, J. et al. Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma. Nat Commun 7, 13080 (2016). https://doi.org/10.1038/ncomms13080
Published:
DOI: https://doi.org/10.1038/ncomms13080
This article is cited by
-
White-light-driven fluorescence switch for super-resolution imaging guided photodynamic and photoacid therapy
Science China Chemistry (2022)
-
MOFs-based nanoagent enables dual mitochondrial damage in synergistic antitumor therapy via oxidative stress and calcium overload
Nature Communications (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
